[1]
Galdy, S. et al. 2016. Oxaliplatin-based second-line chemotherapy in neuroendocrine carcinomas. A case series and review of the literature.
European Journal of Oncology and Environmental Health
. 21, 2 (Jul. 2016), 123–129.